← Leaderboards
Ian Harris Kratter
University Of California, San Francisco
$600,911
Attributed
$600,911
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $547.9K · FY2011–22$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$600,911 · 2
By mechanism
R01$547,869 · 1
F31$53,042 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Stuart James Eisendrath$3,192,303
- Timothy Craig Durazzo$2,141,208
- Karuna Subramaniam$5,290,956
- Jennifer Y. Chen$3,292,676
- Samuel Jeremy Pleasure$23,213,386
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyPatternModificationBrainBehavioralAnteriorAnimalsAgingBehaviorBaseCytoplasmBiologicalAmino AcidsBrain RegionCerebellumAttenuationCell NucleusCessation Of LifeCingulate CortexClinical EffectCognitiveCorpus Striatum StructureCell LineAttenuated
Grant awards (3)
Utilizing changes in human brain connectivity to establish a dose-response relationship involved in the therapeutic actions of prefrontal brain stimulation on depression symptoms$547,869
R01 · FY2022 · MH · contact PI
The in vivo Role of Serine 421 in Huntington's Disease$19,362
F31 · FY2013 · NS · contact PI
The in vivo Role of Serine 421 in Huntington's Disease$33,680
F31 · FY2011 · NS · contact PI